Bo Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bo Wu has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Dingyun Song
Senior Department of Pulmonary and Critical Care Medicine, the Eighth Medical Center of Chinese PLA General Hospital
2 shared publicationsHang Yang
Nanjing Med Univ, Wuxi Peoples Hosp, Lung Transplant Ctr, Wuxi, Peoples R China
2 shared publications- Jingyu Chen
Department of Lung Transplantation, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
2 shared publications Junjie Du
Senior Department of Pulmonary and Critical Care Medicine, the Eighth Medical Center of Chinese PLA General Hospital
2 shared publicationsKeruo Wang
Department of Urology, Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University
2 shared publicationsLicheng Song
Senior Department of Pulmonary and Critical Care Medicine, the Eighth Medical Center of Chinese PLA General Hospital
2 shared publications
Latest Publications
- Open Access
- 24 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1798139
B cell-mediated immune reconstitution after lung transplantation: mechanisms, interventions, and prognostic evaluation
Lung transplantation remains a life-saving option for patients with end-stage lung disease, yet long-term outcomes remain limited by chronic rejection and infection. Although T cells have historically been the focus of transplant immunology, B cells are now recognized as critical regulators of immune responses through the production of antibodies, antigen presentation, and cytokine secretion. These functions contribute to both protective immunity and antibody-mediated rejection (AMR), particularly in the form of donor-specific antibodies (DSAs), which drive chronic lung allograft dysfunction (CLAD). B cell dysregulation can result from ischemia-reperfusion injury (IRI), infection, and immunosuppressive agents such as tacrolimus (TAC), with distinct effects emerging across perioperative and late post-transplant phases. Advances in single-cell RNA sequencing and B cell receptor (BCR) repertoire profiling have enabled precise characterization of B cell dynamics, offering new opportunities for stratified immune monitoring and risk prediction. This review summarizes B cell biology in lung transplantation, outlines stage-specific perturbations, and explores how multi-omics technologies may support personalized immunomodulation and prognostic assessment.
- 24 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1798139
Open AccessB cell-mediated immune reconstitution after lung transplantation: mechanisms, interventions, and prognostic evaluation
Lung transplantation remains a life-saving option for patients with end-stage lung disease, yet long-term outcomes remain limited by chronic rejection and infection. Although T cells have historically been the focus of transplant immunology, B cells are now recognized as critical regulators of immune responses through the production of antibodies, antigen presentation, and cytokine secretion. These functions contribute to both protective immunity and antibody-mediated rejection (AMR), particularly in the form of donor-specific antibodies (DSAs), which drive chronic lung allograft dysfunction (CLAD). B cell dysregulation can result from ischemia-reperfusion injury (IRI), infection, and immunosuppressive agents such as tacrolimus (TAC), with distinct effects emerging across perioperative and late post-transplant phases. Advances in single-cell RNA sequencing and B cell receptor (BCR) repertoire profiling have enabled precise characterization of B cell dynamics, offering new opportunities for stratified immune monitoring and risk prediction. This review summarizes B cell biology in lung transplantation, outlines stage-specific perturbations, and explores how multi-omics technologies may support personalized immunomodulation and prognostic assessment.
- Open Access
- 20 April 2026
- Published by Springer Nature in Respiratory Research
- Vol. 27 (1)
Multi-omics characterises early immune divergence associated with infection-related deterioration after lung transplantation
Early adverse outcomes after lung transplantation often manifest as infection-associated clinical deterioration. Such events are closely intertwined with d
- 20 April 2026
- Published by Springer Nature in Respiratory Research
- Vol. 27 (1)
Open AccessMulti-omics characterises early immune divergence associated with infection-related deterioration after lung transplantation
Early adverse outcomes after lung transplantation often manifest as infection-associated clinical deterioration. Such events are closely intertwined with d
- Open Access
- 5 November 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (1) , 394-401
Impact of donor lung bacteria detected by rapid on-site evaluation on early post-transplant outcomes in lung transplant recipients
- 5 November 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (1) , 394-401
Open AccessImpact of donor lung bacteria detected by rapid on-site evaluation on early post-transplant outcomes in lung transplant recipients
- Open Access
- 13 September 2024
- Published by Elsevier in Journal of Infection
- Vol. 89 (5) , 106273
Pulmonary bacterial infection after lung transplantation: risk factors and impact on short-term mortality
- 13 September 2024
- Published by Elsevier in Journal of Infection
- Vol. 89 (5) , 106273
Open AccessPulmonary bacterial infection after lung transplantation: risk factors and impact on short-term mortality
- Open Access
- 2 April 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (4) , e0314223
Analysis on the change of gut microbiota and metabolome in lung transplant patients
Previous studies have shown that the gut microbiota and its metabolites are associated with the success of organ transplantation. However, the specific changes in the gut microbiota of lung transplant patients remain unclear. Hence, this study aimed to elucidate the interplay between the gut microbiota, metabolome, and lung transplantation outcomes. Using 16S metagenomics sequencing and untargeted metabolic profiling, we conducted a comprehensive analysis of gut microbial and metabolic alterations in lung transplant recipients relative to non-transplant group. Our findings revealed the predominance of Enterococcus and Streptococcus genera within the lung transplant cohort, accompanied by the significant reduction in Bacteroides , Epulopiscium , Faecalibacterium , and Prevotella abundance. In addition, a significant reduction in ATRA (all-trans retinoic acid) levels and suppression of IgA production were observed in lung transplant recipients, which were found to be closely associated with the Enterococcus genus. It was speculated that the association might have implications for the prognosis of lung transplant patients. Notably, the differences in gut microbial composition and metabolomic profiles between successful transplant recipients and those experiencing chronic rejection were not statistically significant. These novel insights shed light on the putative implications of the gut microbiota and metabolome in shaping lung transplantation outcomes, and provide a foundation for future investigations and targeted therapeutic interventions. IMPORTANCE: This study has profound implications for lung transplantation as it uncovers the important role of gut microbiota and metabolome in shaping transplantation outcomes. The identification of dominant bacterial genera, such as Enterococcus and Streptococcus , within the lung transplant cohort, along with the significant decrease in Bacteroides , Epulopiscium , Faecalibacterium , and Prevotella abundance, reveals potential microbial imbalances associated with lung transplantation. In addition, a significant reduction in ATRA (all-trans retinoic acid) levels and suppression of IgA production were observed in lung transplant recipients, which were found to be closely associated with the Enterococcus genus. It was speculated that the association might have implications for the prognosis of lung transplant patients. These findings hold immense clinical significance as they lay the groundwork for future research and targeted therapeutic interventions. Understanding the impact of the gut microbiota and metabolome on lung transplantation outcomes offers promising avenues for improving transplantation patient prognosis.
- 2 April 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (4) , e0314223
Open AccessAnalysis on the change of gut microbiota and metabolome in lung transplant patients
Previous studies have shown that the gut microbiota and its metabolites are associated with the success of organ transplantation. However, the specific changes in the gut microbiota of lung transplant patients remain unclear. Hence, this study aimed to elucidate the interplay between the gut microbiota, metabolome, and lung transplantation outcomes. Using 16S metagenomics sequencing and untargeted metabolic profiling, we conducted a comprehensive analysis of gut microbial and metabolic alterations in lung transplant recipients relative to non-transplant group. Our findings revealed the predominance of Enterococcus and Streptococcus genera within the lung transplant cohort, accompanied by the significant reduction in Bacteroides , Epulopiscium , Faecalibacterium , and Prevotella abundance. In addition, a significant reduction in ATRA (all-trans retinoic acid) levels and suppression of IgA production were observed in lung transplant recipients, which were found to be closely associated with the Enterococcus genus. It was speculated that the association might have implications for the prognosis of lung transplant patients. Notably, the differences in gut microbial composition and metabolomic profiles between successful transplant recipients and those experiencing chronic rejection were not statistically significant. These novel insights shed light on the putative implications of the gut microbiota and metabolome in shaping lung transplantation outcomes, and provide a foundation for future investigations and targeted therapeutic interventions. IMPORTANCE: This study has profound implications for lung transplantation as it uncovers the important role of gut microbiota and metabolome in shaping transplantation outcomes. The identification of dominant bacterial genera, such as Enterococcus and Streptococcus , within the lung transplant cohort, along with the significant decrease in Bacteroides , Epulopiscium , Faecalibacterium , and Prevotella abundance, reveals potential microbial imbalances associated with lung transplantation. In addition, a significant reduction in ATRA (all-trans retinoic acid) levels and suppression of IgA production were observed in lung transplant recipients, which were found to be closely associated with the Enterococcus genus. It was speculated that the association might have implications for the prognosis of lung transplant patients. These findings hold immense clinical significance as they lay the groundwork for future research and targeted therapeutic interventions. Understanding the impact of the gut microbiota and metabolome on lung transplantation outcomes offers promising avenues for improving transplantation patient prognosis.
- 16 May 2020
- Published by Springer Nature
- p. 125-138
ROSE Cytopathology Cases of Pulmonary Infiltration with Eosinophilia
- 16 May 2020
- Published by Springer Nature
- p. 125-138
ROSE Cytopathology Cases of Pulmonary Infiltration with Eosinophilia